Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
about
Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disordersPycnogenol ® for the treatment of chronic disordersPycnogenol ® for the treatment of chronic disordersProanthocyanidin supplements for the treatment of chronic disordersOxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsMitochondrial dysfunction and oxidative stress in Parkinson's diseasePerturbations in dopamine synthesis lead to discrete physiological effects and impact oxidative stress response in Drosophila.Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's DiseaseIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNeuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's diseaseSpecific changes of serum proteins in Parkinson's disease patientsSex differences and effects of estrogenic compounds on the expression of inflammatory molecules by astrocytes exposed to the insecticide dimethoateCDK11(p58) promotes rat astrocyte inflammatory response via activating p38 and JNK pathways induced by lipopolysaccharideA Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotectionThe Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implicationPhosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson diseaseProtective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson's Disease-Like Symptoms in C57BL/6 MouseJNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death.Mitochondrial cell death control in familial Parkinson disease.Plasma DNA Mediate Autonomic Dysfunctions and White Matter Injuries in Patients with Parkinson's DiseaseMicroglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.Loss of Parkin reduces inflammatory arthritis by inhibiting p53 degradationAssociation of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective studyParkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network.Age-related learning and memory deficits in rats: role of altered brain neurotransmitters, acetylcholinesterase activity and changes in antioxidant defense systemPathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia.Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.Lewy bodies.Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autismDrosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO.Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.Zhichan powder regulates nigrostriatal dopamine synthesis and metabolism in Parkinson's disease ratsSelective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesisIntrathecal infusion of hydrogen-rich normal saline attenuates neuropathic pain via inhibition of activation of spinal astrocytes and microglia in rats.Mechanisms of methamphetamine-induced dopaminergic neurotoxicity.Formation of dopamine adducts derived from brain polyunsaturated fatty acids: mechanism for Parkinson diseaseNeuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease.Involvement of Heme Oxygenase-1 Induction in the Cytoprotective and Immunomodulatory Activities of Viola patrinii in Murine Hippocampal and Microglia Cells.
P2860
Q24200455-5D41D7B6-88AC-4005-BADF-FBEA124C0B7DQ24203648-BA5EA329-8F7C-4571-8B0B-3A8664B309F2Q24234436-52619AC4-DB51-4436-94A1-CF5ACEAD3726Q24241265-DFD1C676-499D-4AF4-BF52-8C75FC7514F2Q24337079-3DFFA8FD-F974-452D-B625-E72E36CAD2ABQ26801035-9930F677-4DBA-4D3B-8BAC-9F0E03852253Q27014051-8FE9FC1A-1C27-441A-98ED-B687B5BD2977Q27309825-87C1EA58-34F2-49E6-8E43-88D42CEB836FQ28277871-269F742F-2204-43A7-9446-22AE4EBC5815Q28388335-41EA309B-570B-4038-A428-B431F039AFDBQ28482356-4E3905AF-1343-4955-928E-5BDA979667D1Q28538260-95DF0CAD-8386-48AC-808E-B4D6D6B733C4Q28570210-A3799EB8-49D9-42E6-A35E-A52701CB68E0Q28583492-A7A02057-4CD6-4506-A175-96748FA51490Q28589470-0376D740-E9FB-4B4D-8ED6-C5FF3171399CQ28604244-6DBD53C3-BBA7-4D14-A8E0-885618ACD1F0Q28742424-8631C7B3-771F-4371-95BD-06A70EF9A72FQ30393313-25FBBD12-4E95-487B-BA42-ACD526AF20D1Q30498929-291C67A4-98B2-4053-A07A-CE74DCC9197AQ33291145-3445F454-FD61-45DA-B906-A59930E65382Q33364851-211E1950-E476-4093-831B-5510BB1F7970Q33526342-526D51BE-1571-464F-B22F-4C046366BF26Q33555712-595C5CDF-1513-41F1-ADD9-36B9ADC8703BQ33637422-3F650595-D629-465D-A774-6CA1213518F0Q33746288-EB796C3D-4457-455E-A95C-FC5EAE3563E8Q33848621-BBC4F4C7-4ED9-4933-A488-66FD5C46CF6CQ33891870-B2D9118C-2264-417B-9A27-66F8D175C555Q33913000-53DF6358-D981-4515-A098-5174637B9B4DQ33925236-54396531-D95E-4CE6-9E3F-DC152368E703Q34478663-D10F5CE9-6353-44CC-A00D-5ED033230216Q34599738-7B623983-9039-4A9C-B8B8-9F83A525CDF0Q34671965-1E269527-7511-479C-B95C-5CC22AA65624Q34738778-8B29BDF9-EA18-479E-93D3-FFD5A23269FFQ34798682-A51D3CE4-37F0-4545-AE3D-5B5087742D2EQ35123174-5528D6FB-F833-4622-922E-F5CF3BE656FFQ35173285-D9FED180-1B10-4C03-9DA9-666951ADFA2CQ35594901-AB84CA2D-CCEB-48D3-8C2B-862B0AA981E1Q35676862-A77F3920-A9AA-4105-B854-92C36259F1B1Q35808114-4D8C35ED-4C3E-419E-821B-81D2109D614AQ35872370-2B21778F-EC3B-4111-A78F-4C263EC0427F
P2860
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@ast
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@en
type
label
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@ast
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@en
prefLabel
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@ast
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@en
P1476
Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
@en
P2093
Andreas Hald
Julie Lotharius
P304
P356
10.1016/J.EXPNEUROL.2005.01.013
P407
P577
2005-06-01T00:00:00Z